Comprehensive transcriptomic analysis to identify biological and clinical differences in cholangiocarcinoma
Abstract Background Cholangiocarcinoma (CC) is a rare and aggressive disease with limited therapeutic options and a poor prognosis. All available public records of cohorts reporting transcriptomic data on intrahepatic cholangiocarcinoma (ICC) and extrahepatic cholangiocarcinoma (ECC) were collected...
Main Authors: | Marco Silvestri, Trung Nghia Vu, Federico Nichetti, Monica Niger, Serena Di Cosimo, Filippo De Braud, Giancarlo Pruneri, Yudi Pawitan, Stefano Calza, Vera Cappelletti |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-04-01
|
Series: | Cancer Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1002/cam4.5719 |
Similar Items
-
High expression of protein tyrosine phosphatase receptor S (PTPRS) is an independent prognostic marker for cholangiocarcinoma
by: Muntinee Lertpanprom, et al.
Published: (2022-08-01) -
Bioinformatics analysis identified CDC20 as a potential drug target for cholangiocarcinoma
by: Prin Sungwan, et al.
Published: (2021-03-01) -
PIWIL4 and SUPT5H combine to predict prognosis and immune landscape in intrahepatic cholangiocarcinoma
by: Wenbo Zou, et al.
Published: (2021-12-01) -
ACSL4 serves as a novel prognostic biomarker correlated with immune infiltration in Cholangiocarcinoma
by: Shuochen Liu, et al.
Published: (2023-05-01) -
Prediction of immune infiltration and prognosis for patients with cholangiocarcinoma based on a cuproptosis-related lncRNA signature
by: Hong-Fei Yao, et al.
Published: (2024-01-01)